A Physiologic model for simulating gastrointestinal flow and drug absorption in rats

被引:72
作者
Willmann, S [1 ]
Schmitt, W
Keldenich, J
Dressman, JB
机构
[1] Bayer AG, Bayer Technol Serv, D-51368 Leverkusen, Germany
[2] Bayer AG, Bayer Hlth Care, Chem Res, D-42096 Wuppertal, Germany
[3] Goethe Univ Frankfurt, Inst Pharmaceut Technol, D-60439 Frankfurt, Germany
关键词
PB-PK modeling; simulation; intestinal absorption; fraction dose absorbed;
D O I
10.1023/B:PHAM.0000003373.72652.c0
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The development of a physiologically based absorption model for orally administered drugs in rats is described. Methods. Unlike other models that use a multicompartmental approach, the GI tract is modeled as a continuous tube with spatially varying properties. The mass transport through the intestinal lumen is described via an intestinal transit function. The only substance-specific input parameters of the model are the intestinal permeability coefficient and the solubility in the intestinal fluid. With this physiologic and physicochemical information, the complete temporal and spatial absorption profile can be calculated. Results. A first performance test using portal concentration data published in the literature yielded an excellent agreement between measured and simulated temporal absorption profiles in the portal vein. Furthermore, the dose dependence of a compound with solubility-limited fraction dose absorbed in rats (chlorothiazide) could be adequately described by the model. Conclusions. The continuous absorption model is well suited to simulate drug flow and absorption in the GI tract of rats.
引用
收藏
页码:1766 / 1771
页数:6
相关论文
共 31 条
[1]   Predicting the impact of physiological and biochemical processes on oral drug bioavailability [J].
Agoram, B ;
Woltosz, WS ;
Bolger, MB .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 50 :S41-S67
[2]  
Bajpai M, 2000, Curr Opin Drug Discov Devel, V3, P63
[3]   Predicting drug absorption: How nature made it a difficult problem [J].
Burton, PS ;
Goodwin, JT ;
Vidmar, TJ ;
Amore, BM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03) :889-895
[4]  
Chiou WL, 2000, INT J CLIN PHARM TH, V38, P532
[5]   PHYSICOCHEMICAL MODEL FOR DOSE-DEPENDENT DRUG ABSORPTION [J].
DRESSMAN, JB ;
FLEISHER, D ;
AMIDON, GL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (09) :1274-1279
[6]  
FISCHER RB, 1957, J ANAT, V84, P272
[7]   Biopharmaceutical characterization of oral immediate release drug products.: In vitro in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin [J].
Frick, A ;
Möller, H ;
Wirbitzki, E .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 46 (03) :305-311
[8]   Local absorption kinetics of levofloxacin from intestinal tract into portal vein in conscious rat using portal-venous concentration difference [J].
Fujieda, Y ;
Yamaoka, K ;
Ito, T ;
Nakagawa, T .
PHARMACEUTICAL RESEARCH, 1996, 13 (08) :1201-1204
[9]   Simulation models to predict oral drug absorption from in vitro data [J].
Grass, GM .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) :199-219
[10]   Physiologically-based pharmacokinetic simulation modelling [J].
Grass, GM ;
Sinko, PJ .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (03) :433-451